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Background. The impact of invasive methods of treatment on results in developing countries may diﬀer from that in developed
countries. Methods. This is a prospective clinical study of consecutive patients with Subarachnoid Haemorrhage (SAH) admitted
to the Ghaem Hospital, Mashhad during the period from 2005 to 2009. The initial diagnosis and investigations were carried out
by neurologists. The patients were divided into two groups. One received surgical treatment whilst the other group was managed
medically. The decision as to the choice of the method of treatment was made by the neurosurgeons. The initial medical treatment
was standardised for all the patients. The rate of complications and mortality was compared in both medical and surgical groups.
Results.120SAHpatients(52%females)withameanageof50.6±7yearswereevaluated.Theangiographyrevealed thepresence of
ananeurysmin62patients.63.5%ofthepatientsreceived medicaltreatmentand37.5%underwentaneurysmalsurgery.Diﬀerence
of rebleeding rate in the two therapeutic groups was not signiﬁcant; X2 = .014, P = .91. The eﬀect of rebleeding on mortality was
not signiﬁcant; X2 = 2.54, P = .14. Within 62 SAH patients with cerebral aneurysm, the mortality rate in both therapeutic groups
was also not signiﬁcantly diﬀerent; X2 = .16, P = .77. Conclusion. There is no signiﬁcant diﬀerence in the mortality rate between
the “surgical” and non-“surgical” groups of Iranian patients with SAH. This could be due to delay in performance of surgery in
Iranian neurovascular centers.
1.Introduction
The outcome for patients with SAH remains poor, with
mortality rates up to 45%, and there is signiﬁcant morbidity
amongsurvivors[1].Thereviewofliteratureandprospective
cohorts has shown that for untreated, ruptured aneurysms,
there is at least a 3-4% risk of rebleeding in the ﬁrst 24 hours
and 1-2%per dayin theﬁrst month [2].Urgentinvestigation
and treatment of patients with suspected SAH is therefore
recommended [2]. The major complications following SAH
are due to ischaemic deﬁcit (27%) and hydrocephalus (12%)
[3]. However the most feared complication for survivors of
the initial haemorrhage is recurrent bleeding, which occurs
in 15–20% of the patients and is associated with a 40–
78% mortality [3]. The deﬁnitive method for prevention of
rebleeding is to secure the aneurysm as soon as possible [2].
Early surgery may not be appropriate for every patient
with SAH, but every attempt should be made to secure
the aneurysm as soon as possible to prevent rebleeding [3].
Unfortunately, in Iran many patients with SAH are admitted
to hospitals without facilities for catheter angiography,
aneurysmal coiling, or direct aneurysmal surgery. Even in
tertiary care hospitals with these facilities, many of the SAH
patients are admitted after 3 days following the ictus, and for
this reason the surgical or endovascular treatment is delayed
for up to 3 weeks after event. Unfortunately, there is no
policy of urgency in the Iranian emergency departments to
direct the patients with SAH to appropriate management.
Additionally,someoftheIranianSAHpatientsrefusesurgery
onculturaloreconomicgrounds.In thispaper, wereport the
ﬁrst prospective studyof aneurysmal surgery in patientswith
SAH in Iran.2 Stroke Research and Treatment
2.PatientsandMethods
Consecutive patients with subarachnoid hemorrhage (SAH)
admitted in the Ghaem Hospital, Mashhad during 2005–
2009 were enrolled in a prospective clinical study. Ghaem
hospital is a university tertiary care center the in northeast
of Iran. Neurologists, neurosurgeons, and radiologists are
available 24 hours per day and 7 days per week in Ghaem
Hospital. SAH patients who died before arriving to hospital
were excluded from this study. The initial Hunt and Hess
scale for each SAH patient on arrival to the hospital was
recorded in both therapeutic groups. Diagnosis of SAH was
based on a brain CT scan. Patients suspected to have a SAH
butwithnormalbrainCTscanunderwentaFLAIRMRIscan
and lumbar puncture [4, 5]. Catheter cerebral angiography
is a routine diagnostic investigation in our SAH patients
and is performed by general radiologists. SAH patients with
an initially normal cerebral angiography usually underwent
a second angiography after 3 weeks. Patients who did not
have cerebral angiography due to poor medical condition,
early death in hospital, or allergy to contrast material were
excluded. Positive angiograms for aneurysm were found
in 63.5% of our SAH patients. SAH patients were usually
admitted for 3 weeks in either neurology or neurosurgery
divisions. In our center, cerebral angiography followed by
aneurysmal clipping is usually performed on patients with
SAH within the ﬁrst 72 hours after SAH. Patients who
arrive to hospital after this time or were initially comatose
were usually medically treated, and diagnostic procedures
and surgery, if required, were performed in this group of
cases after 3 weeks after event. SAH patients who underwent
craniotomy and aneurysmal clipping were categorized as
a surgical therapeutic group. Aneurysmal clipping with
the aid of a microscope is the usual type of surgical
procedure in our hospital for these patients. Aneurysmal
wrapping is not performed and endovascular coiling is not
available. Patients who underwent ventricular shunting for
hydrocephalus without aneurysmal clipping were included
in the medical therapeutic group. Surgical decision for
the patient with aneurysm was made by a neurosurgeon.
General medical condition of the patients was assessed by
anesthetists and patients with poor cardiopulmonary or
medical condition were excluded. SAH patients with Hunt
and Hess scale of5 were also excluded.Despiteneurosurgical
recommendation, some of our patients refused surgery due
toculturalaspectsorlackoffunds.Themedicalmanagement
received was standardized in both surgical and medical
groups of SAH patients. Principles of medical management
included analgesia, nimodipine, sedatives, laxatives, control
ofblood pressure, and 3 litres ofnormal saline per day [4, 5].
Demographic features, risk factors, cerebral CT ﬁndings,
clinical manifestations and aneurysm characteristics were
evaluated in all patients. Mortality and complications in
SAH, including rebleeding, hydrocephalus, and brain infarc-
tion due to vasospasm, were recorded in both medical and
surgical groups of patients during hospitalization. The time
was recorded and comparison made in each therapeutic
group from SAH onset to hospital arrival, SAH onset to
death, SAH onset to surgery (where applicable), and surgery
(where applicable) to death in all patients. Chi-square and
Fisher tests were used for statistical analysis, and P<. 05 was
declared as signiﬁcant. The research project was approved by
the ethics committee of Ghaem Hospital, and an informed
signed consent was taken from patients or their ﬁrst-degree
relatives.
3.Results
The results of the treatment ofone hundred and twenty SAH
patients (63 females, 57 males) with a mean age 50.6±7
years were prospectively evaluated. Patients with exclusion
criteria are not considered in these 120SAH cases. SAH
was detected on cerebral CT in 95% of the cases. The
patients were divided into two therapeutic groups. Among
our SAH patients, 62.5% with mean age 52.4±5 received
medical treatment and 37.5% with mean age 49.7±3w e r e
subjected to surgery. Hypertension, smoking, oral contra-
ceptive medication, past trauma, and overdosage of oral
anticoagulation therapy were found in 41.6%, 19.1%, 0%,
0%, and .8% of patients, respectively. Fifty-six patients were
subjected to surgery, of whom 45 underwent craniotomy
and aneurysmal clipping, while 11 cases had CSF shunting
without aneurysmal clipping and were included into the
medically managed group. Overall mortality was 44.2% of
all SAH patients (60.4% of females and 39.6% of males).
There was no statistically signiﬁcant diﬀerence in the death
rate between the two therapeutic groups (X2 = 1.54, df = 1,
P = .11) and no signiﬁcant diﬀerence between the females
and males (X2 = .73, df = 1, P = .39). The mean SAH
onset to admission time in whole of our SAH patients and
in their medical and surgical groups was 66±4, 84±1,
and 24±7 hours, respectively. The overall mean timing
from the onset of SAH to death was 14.1±2d a y s .I nt h e
surgical group, the mean length of time from onset of SAH
to surgery was 8.4±3 days, and for those who died, the
mean length of the time between surgery and death was
5.9±3d a y s .Table 1 compares the characteristics between
surgical and medical groups. The eﬀect of therapeutic type
of aneurysm management on mortality was not signiﬁcant;
X2 = 0.16, P = .77. Rebleeding occurred in 4.4% of
patients in the surgical group and 4% in the medical group
and the diﬀerence was not statistically signiﬁcant; X2 =
.014, P = .91. Among 5SAH patients with rebleeding, 2
had an anterior communicating artery aneurysm and 3 had
a “normal angiography.” The inﬂuence of rebleeding on the
overall mortality was not statistically signiﬁcant; X2 = 2.54,
P = .14. None of the patients studied had rebleeding before
admission to hospital. However, rebleeding might have
occurred in patientswho died before arriving to the hospital,
and these were not included in this study. Hydrocephalus
was found in 17 patients, and its frequency was signiﬁcantly
diﬀerent in the two therapeutic groups; X2 = 5.58, P =
.03. Out of 17 SAH patients with hydrocephalus, 13 (76%)
died, and the eﬀect of hydrocephalus on the mortality of
these patients was signiﬁcant; X2 = 7.93, P = .007.
Cerebral infarction due to vasospasm occurred in 7 (5.8%)
patients (4.4% of the surgical and 6.7% of the medical
group). The eﬀect of aneurysmal therapeutic strategy onStroke Research and Treatment 3
Table 1: Clinical characteristics of surgical and medical groups of our SAH patients.
Therapeutic group/H-H-S∗ H-H-S 1 H-H-S 2 H-H-S 3 H-H-S 4 H-H-S 5 Death
Surgical (n: 45) (F: 25, M: 20) 1 14 24 6 — 28 (62.2%)
Medical without aneurysm (n: 58) (F: 29, M: 29) 1 12 26 11 8 18 (31%)
Medical with aneurysm (n: 17) (F: 9, M: 8) — — — 7 10 7 (41.2%)
Total (n: 120) (F: 63, M: 57) 2 26 50 24 18 53 (44.2%)
H-H-S: Hunt Hess Scale.
∗None of our SAH patients had Hunt Hess scale 0.
Table 2: Distribution of complications and outcome in the two therapeutic groups of our SAH patients.
Therapeutic group Rebleeding Death due to
rebleeding
Hydrocephaly Ventricular shunting Infarction due to
vasospasm
Death
Surgical (n: 45) 2 (4.4%)∗ — 2 (4.4%) 2 (4.4%) 2 (4.4%) 28 (62.2%)
Medical (n: 75) 3( 4 % ) 2( 2 . 7 % ) 15 (20%) 11 (14.7%) 5 (6.7%) 25 (33.3%)
Total (n: 120) 5 (4.2%) 2 (1.7%) 17 (14.2%) 13 (10.8%) 7 (5.8%) 53 (44.2%)
Rebleeding occurred before aneurysmclipping.
Table 3:Causesofdeathin surgicalandmedicalgroups ofourSAH
patients.
Cause of death/therapeutic group Medical
(n: 75)
Surgical
(n: 45)
Cerebral infarction 1 2
Rebleeding 2 —
Hydrocephalus 13 —
Pulmonary embolism 1 2
Acute myocardial infarction 1 3
Electrolyte balance derangement 2 4
Ventricular tachycardia 2 3
Acute tubular necrosis — 1
Pneumonia 1 2
Intraoperative — 3
Unknown 5 5
Total 28 25
frequency of cerebral infarction was not signiﬁcant; X2 =
0.25, P = .71. Out of seven patients with brain infarction
due to vasospasm, three cases died. The eﬀect of cerebral
infarction on the overall mortality of SAH patients was not
signiﬁcant; X2 = 0.005, P = 1. Table 2 represents the
distribution of complications in two therapeutic groups of
our patients. Aneurysms were found in the angiography of
62 patients (45 in the surgical and 17 in the medical group).
The distribution was as follows: anterior communicating
artery 41.9%, middle cerebral artery 23.1%, internal carotid
artery 14.5%, basilar artery 4.8%, anterior cerebral artery
4.8%, posterior communicating artery 6.4%, and multiple
aneurysms 3%. Among 62 SAH patients with aneurysm
on angiography, 45 patients (72.6%) underwent aneurysm
surgery and 17 cases (27.4%) received only medical man-
agement. Death was recorded in 48.9% of SAH patients
with aneurysm who underwent aneurysm surgery (22/45)
and 41.2% of patients with aneurysm who only received
medicalmanagement(7/17).HighHuntandHessscale,poor
generalmedicalcondition,andrefusal ofpatientsconstituted
reasons of excluding these 17 cases with aneurysm from
surgical group in 58.8%, 29.4%, and 11.7%, respectively.
Details of Hunt and Hess scales of these seventeen cases are
presented in Table 1.T h ed i ﬀerence in the mortality rate in
62SAHpatients with angiographically conﬁrmed aneurysms
in two therapeutic groups was not statistically signiﬁcant;
X2 = .16, P = .77. Table 3 illustrates causes of death in
surgical and medical groups of our SAH patients.
4.Discussion
This study concerned SAH patients admitted alive; thus,
the prehospital mortality is unknown in our SAH patients.
Our hospital-based study revealed an incidence of negative
angiography in 58/120 (48.3%). In other study from Iran,
the incidence of negative angiography among SAH patients
was reported to be 35/108 (32.4%) [6]. This is strikingly
diﬀerent from ﬁndings in Europe, Japan, and the USA,where
studies have reported a 15–20% negative angiography result
in SAH [1]. In aneurysmal surgery, delay in treatment is
associated with increased rates of preoperative rebleeding,
in both retrospective and prospective studies [2]. Recently
it has been associated with higher rates of poor outcome
[2, 7]. The International Cooperative Study on the Tim-
ing of Aneurysmal Surgery analysed management of 3521
patients, of whom 83% underwent surgical repair of the
ruptured aneurysm [8]. The timing of surgery after SAH
was signiﬁcantly related to the likelihood of preoperative
rebleeding. Patients who underwent early surgery had a
signiﬁcantly lower preoperative rebleeding rate than those
who underwent latersurgery (3%versus11%)[8].Themean
time of onset to surgery in our SAH patients was 8 days
which is longer than that reported in western countries [7].
This signiﬁcant delay in the timing of aneurysmal surgery
in our patients could be the main reason for failure to
decrease mortality in our patients. During this period of
delay, a number of complications may occur in the surgical4 Stroke Research and Treatment
group. In recent years, there has been a trend towards early
surgery for ruptured aneurysms, especially in good- and
moderate-grade patients [2, 7]. In addition, early surgery
facilitates the possibility of aggressive therapy of vasospasm
[2]. However, it is also reported that there were no overall
diﬀerences in outcome in patients operated on early (0–
3 days after SAH) or late (11–14 days after SAH) [7].
Surgical mortality was higher with early surgery due to
brain swelling, disturbed autoregulation, and haemorrhage
[7]. The treatment was most hazardous between days 7 and
10 due to the combined risks of rebleeding and vasospasm
[7]. A prospective study, from three centers, indicates that
despite attempts to do early surgery, rebleeding is still a
signiﬁcant problem, because only one half of the patients
were operated on within 72 hours, and 35% of the patients
with poor outcome had suﬀered rebleeding [9, 10]. In
addition, some SAH patients with acute hydrocephalus may
beneﬁt from early placement of a ventricular drain in the
hospital [11]. Acute hydrocephalus is more frequent in
patients with poor clinical grade. The clinical signiﬁcance of
acute hydrocephalus after SAH is uncertain because many
patients are apparently asymptomatic and do not deteriorate
[2]. There was no statistical signiﬁcance between type of
management, mortality, and complications in our patients.
The impact of rebleeding despite presence of hydrocephalus
on mortality was not signiﬁcant in our patients. This is
inconsistent with results in developed countries [12]. The
latepresentationoftheSAHpatientsinourcenter,compared
to developed countries, is a local issue, and this leads to
late treatment. The logistic multivariate regression test is
necessary, to access the exact inﬂuence of the therapeutic
subtype of aneurysm, on in-hospital death in SAH patients.
However, this type of analysis needs more than ﬁve hundred
SAH cases, which is out of our reach in the near future.
Meanwhile, we consider our work the ﬁrst pilot study
conducted in Iran. Management of SAH patients in Iran is
still suﬀering from major diﬃculties. Whether the obstacles
are situated mainly on the diagnostic, technical, or intensive
care level should be investigated in next studies.
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